Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Possible link between FSH and RANKL release from adipocytes in men with impaired gonadal function including Klinefelter syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Calcium transport in male reproduction is possibly influenced by vitamin D and CaSR

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Accelerated loss of oogonia and impaired folliculogenesis in females with Turner syndrome start during early fetal development

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Thyroid function in COVID-19 and the association with cytokine levels and mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The effects of selected inhibitors on human fetal adrenal steroidogenesis differs under basal and ACTH-stimulated conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Introduction: The FSH receptor (FSHR) has been found to be expressed in human bone cells and bone marrow-adipocytes, and highly-debated mouse studies have suggested extra-gonadal effects of gonadotropins on glucose, adipocyte and bone homeostasis. These putative effects could be direct or indirectly mediated by endocrine factors released from bone-cells or adipocytes. Here, we investigated whether gonadotropins are linked with glucose- and lipid-metabolism in hypergonadotropic men. Methods: Single centre, cross-sectional study of 307 men with idiopathic infertility and 28 men with Klinefelter syndrome (KS). Outcome: associations between serum LH and FSH with soluble-RANKL (sRANKL), osteoprotegerin (OPG), osteocalcin, fasting glucose and insulin, sex steroids, and body composition. Expression of FSHR was studied in human-derived adipocyte-cell-models (hMADS, TERT-hWA) and FSH stimulation of RANKL expression and secretion in hMADS in vitro. Results: Serum FSH was not directly linked with glucose- and lipid-metabolism. However, FSH was inversely associated with sRANKL in both infertile men and KS men (p =.023 and p =.012). Infertile men with elevated FSH (>11 U/L) had significantly lower sRANKL (p =.015). sRANKL was positively associated with fat percentage, fasting insulin, and glucose (all p <.05). Men with prediabetes had higher sRANKL (p =.021), but lower testosterone (p <.0001) and Inhibin B (p =.005). The FSHR was expressed in the investigated human derived adipocytes, and 3–6 h treatment with FSH markedly increased RANKL release (p <.05). Conclusion: KS and infertile men with prediabetes have low Inhibin B, and testosterone but elevated RANKL compared with non-prediabetic men despite comparable levels of serum gonadotropins. Serum FSH and sRANKL was inversely associated in both infertile and KS men, but the increased release of RANKL from FSH treated adipocytes suggest a direct effect of FSH on RANKL production in some tissues. Further studies are required to clarify whether FSH targets RANKL in the skeleton. ClinicalTrial_ID:NCT01304927

Original languageEnglish
Pages (from-to)103-114
Number of pages12
Publication statusPublished - Jun 2019

Bibliographical note

Copyright © 2019 Elsevier Inc. All rights reserved.

ID: 56891504